Ingenuity and initiative in Australian radio astronomy: the Dover Heights ‘hole-in-the-ground’ antenna

During the 1950s staff from the CSIRO's Division of Radiophysics based at the Dover Heights field station employed ingenuity and initiative in response to a lack of funding and support for a new radio telescope. In order to obtain the requisite aperture for the resolution sought they spent their own time excavating a 21.9-m parabolic depression in the sand at the field station, and when the viability of this prototype transit instrument was established its diameter was increased to 24.4 m, making this the largest radio telescope in Australia at the time. Operating at 400 MHz, this instrument was employed to map the galactic centre region and in a search for new discrete sources. It also was used to investigate polarization in the plane of the Galaxy, and in an unsuccessful search for the newly-proposed deuterium line. Today the Dover Heights "hole-in-the-ground" antenna lies buried beneath Rodney Reserve, and there is little at this public playing field to remind visitors of the important contributions made by this radio telescope, and others at this site, during the formative years of Australian radio astronomy

Early Australian Optical and Radio Observations of Centaurus A

The discoveries of the radio source Centaurus A and its optical counterpart NGC 5128 were important landmarks in the history of Australian astronomy. NGC 5128 was first observed in August 1826 by James Dunlop during a survey of southern objects at the Parramatta Observatory, west of the settlement at Sydney Cove. The observatory had been founded a few years earlier by Thomas Brisbane, the new governor of the British colony of New South Wales. Just over 120 years later, John Bolton, Gordon Stanley and Bruce Slee discovered the radio source Centaurus A at the Dover Heights field station in Sydney, operated by CSIRO's Radiophysics Laboratory (the forerunner of the Australia Telescope National Facility). This paper will describe this early historical work and summarise further studies of Centaurus A by other Radiophysics groups up to 1960.Comment: 45 pages, 43 figure

A Chandra Observation of Abell 13: Investigating the Origin of the Radio Relic

We present results from the Chandra X-ray observation of Abell 13, a galaxy cluster that contains an unusual noncentral radio source, also known as a radio relic. This is the first pointed X-ray observation of Abell 13, providing a more sensitive study of the properties of the X-ray gas. The X-ray emission from Abell 13 is extended to the northwest of the X-ray peak and shows substructure indicative of a recent merger event. The cluster X-ray emission is centered on the bright galaxy H of Slee et al. 2001. We find no evidence for a cooling flow in the cluster. A knot of excess X-ray emission is coincident with the other bright elliptical galaxy F. This knot of emission has properties similar to the enhanced emission associated with the large galaxies in the Coma cluster. With these Chandra data we are able to compare the properties of the hot X-ray gas with those of the radio relic from VLA data, to study the interaction of the X-ray gas with the radio emitting electrons. Our results suggest that the radio relic is associated with cooler gas in the cluster. We suggest two explanations for the coincidence of the cooler gas and radio source. First, the gas may have been uplifted by the radio relic from the cluster core. Alternatively, the relic and cool gas may have been displaced from the central galaxy during the cluster merger event.Comment: 11 pages, 9 figures, Accepted for Publication in the Astrophysical Journal, higher-resolution figures can be found at http://www.astro.virginia.edu/~amj3r/Abell13

Effects of canagliflozin on initiation of insulin and other antihyperglycaemic agents in the CANVAS program

This study compared initiation of insulin and other AHAs with canagliflozin versus placebo for participants with type 2 diabetes and a history/high risk of cardiovascular disease in the CANagliflozin cardioVascular Assessment Study (CANVAS) Program. After 1 year fewer participants treated with canagliflozin versus placebo initiated any AHA (7% vs 16%), insulin (3% vs 9%;) or any non-insulin AHA (5% vs 12%; p<0.001 for all); overall AHA initiation rates increased over time but were consistently lower with canagliflozin compared with placebo. During the study, the likelihood of initiating insulin was 2.7 times lower for participants treated with canagliflozin compared with placebo (hazard ratio, 0.37; 95% CI: 0.31,0.43; p<0.001). The time difference between 10% of patients in the canagliflozin and placebo groups being initiated on insulin from the beginning of the trial was about two years. Time to initiation of other AHAs, including metformin, dipeptidyl peptidase-4 inhibitors, glucagon-like peptide-1 receptor agonists and sulphonylureas, was also delayed for canagliflozin versus placebo (p<0.001 for each). Compared with placebo, canagliflozin delayed the need for initiation of other AHAs and delayed time to insulin therapy, an outcome that is important to many people with diabetes. Trial registration: ClinicalTrials.gov identifiers NCT01032629, NCT01989754. This article is protected by copyright. All rights reserved

Bcl-2 protein family: Implications in vascular apoptosis and atherosclerosis

Apoptosis has been recognized as a central component in the pathogenesis of atherosclerosis, in addition to the other human pathologies such as cancer and diabetes. The pathophysiology of atherosclerosis is complex, involving both apoptosis and proliferation at different phases of its progression. Oxidative modification of lipids and inflammation differentially regulate the apoptotic and proliferative responses of vascular cells during progression of the atherosclerotic lesion. Bcl-2 proteins act as the major regulators of extrinsic and intrinsic apoptosis signalling pathways and more recently it has become evident that they mediate the apoptotic response of vascular cells in response to oxidation and inflammation either in a provocative or an inhibitory mode of action. Here we address Bcl-2 proteins as major therapeutic targets for the treatment of atherosclerosis and underscore the need for the novel preventive and therapeutic interventions against atherosclerosis, which should be designed in the light of molecular mechanisms regulating apoptosis of vascular cells in atherosclerotic lesions

A Transcription Factor Map as Revealed by a Genome-Wide Gene Expression Analysis of Whole-Blood mRNA Transcriptome in Multiple Sclerosis

Background: Several lines of evidence suggest that transcription factors are involved in the pathogenesis of Multiple Sclerosis (MS) but complete mapping of the whole network has been elusive. One of the reasons is that there are several clinical subtypes of MS and transcription factors that may be involved in one subtype may not be in others. We investigate the possibility that this network could be mapped using microarray technologies and contemporary bioinformatics methods on a dataset derived from whole blood in 99 untreated MS patients (36 Relapse Remitting MS, 43 Primary Progressive MS, and 20 Secondary Progressive MS) and 45 age-matched healthy controls. Methodology/Principal Findings: We have used two different analytical methodologies: a non-standard differential expression analysis and a differential co-expression analysis, which have converged on a significant number of regulatory motifs that are statistically overrepresented in genes that are either differentially expressed (or differentially co-expressed) in cases and controls (e.g., V$KROX_Q6, p-value ,3.31E-6; V$CREBP1_Q2, p-value ,9.93E-6, V$YY1_02, p-value ,1.65E-5). Conclusions/Significance: Our analysis uncovered a network of transcription factors that potentially dysregulate several genes in MS or one or more of its disease subtypes. The most significant transcription factor motifs were for the Early Growth Response EGR/KROX family, ATF2, YY1 (Yin and Yang 1), E2F-1/DP-1 and E2F-4/DP-2 heterodimers, SOX5, and CREB and ATF families. These transcription factors are involved in early T-lymphocyte specification and commitment as well as in oligodendrocyte dedifferentiation and development, both pathways that have significant biological plausibility in MS causation

A new era in the treatment of multiple sclerosis

Multiple sclerosis (MS) is an autoimmune disease of the central nervous system with a multifactorial aetiology and highly variable natural history. A growing understanding of the immunopathogenesis of the condition has led to an expanding array of therapies for this previously untreatable disease. While a cure for MS remains elusive, the potential to reduce inflammatory disease activity by preventing relapses and minimising disease progression is achievable. The importance of early treatment in minimising long-term disability is increasingly recognised. Most of the newer, more effective therapies are associated with risks and practical problems that necessitate an active management strategy and continuous vigilance. While the initiation of these therapies is likely to remain the responsibility of neurologists, other specialist physicians and general practitioners will be involved in the identification and management of adverse effects

Comparing genotyping algorithms for Illumina's Infinium whole-genome SNP BeadChips

The Brassica napus 60K Illumina Infinium™ SNP array has had huge international uptake in the rapeseed community due to the revolutionary speed of acquisition and ease of analysis of this high-throughput genotyping data, particularly when coupled with the newly available reference genome sequence. However, further utilization of this valuable resource can be optimized by better understanding the promises and pitfalls of SNP arrays. We outline how best to analyze Brassica SNP marker array data for diverse applications, including linkage and association mapping, genetic diversity and genomic introgression studies. We present data on which SNPs are locus-specific in winter, semi-winter and spring B. napus germplasm pools, rather than amplifying both an A-genome and a C-genome locus or multiple loci. Common issues that arise when analyzing array data will be discussed, particularly those unique to SNP markers and how to deal with these for practical applications in Brassica breeding applications